Disclosures for "Pathogenic Variation in Fibrillin-2 Confers Susceptibility to Spontaneous Cerebrospinal Fluid Leaks Through Impairment of Cellular Adhesion"
-
Ms. Parks has nothing to disclose.
-
Dr. Singh has nothing to disclose.
-
Mrs. Wohler has nothing to disclose.
-
Dr. Paulo Martin has nothing to disclose.
-
Dr. Juzwiak has nothing to disclose.
-
Miss Sun has nothing to disclose.
-
Mrs. Peeters has nothing to disclose.
-
Prof. Loeys has nothing to disclose.
-
Dr. Sobreira has received personal compensation in the range of $500-$4,999 for serving as a Consultant for DASA. The institution of Dr. Sobreira has received research support from NIH.
-
Prof. Baldock has received personal compensation in the range of $0-$499 for serving as a Consultant for Engitix. Prof. Baldock has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Matrix Biology, Elsevier. The institution of Prof. Baldock has received research support from BBSRC. The institution of Prof. Baldock has received research support from Wellcome.
-
Dr. Schievink has nothing to disclose.
-
Dr. Dietz has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for AYTU. Dr. Dietz has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for GSK. Dr. Dietz has stock in GSK. Dr. Dietz has received intellectual property interests from a discovery or technology relating to health care.